✦ LIBER ✦

Bioequivalence: Issues and Options

✍ Scribed by Kamal K. Midha; Maureen J. Rawson; John W. Hubbard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Issues of bioequivalence and cost equiva

✍ Hesham G Al-Inany 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 14 KB

Hydrogen Supply Options and Issues

✍ Kathleen A. Kuberka; Mark K. Weise; Celeste A. Messina 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 519 KB

Issues and anwers: therapeutIc options

✍ A. M. Gotto Jr. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Blood Management: Issues and Options

✍ John J. Callaghan; Michael R. O'Rourke; Steve S. Liu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Biosimilar therapeutic agents: issues wi

✍ H. Schellekens 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Journal impact factors: a ‘bioequivalenc

✍ A. Rostami-Hodjegan; G.T. Tucker 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB